# Early-onset phenotype in a patient with an intermediate allele and a large SCA1 expansion: a case report

**Authors:** Guillaume Baille, Nicolas Geoffre, Anna Wissocq, Pauline Planté-Bordeneuve, Eugénie Mutez, Vincent Huin

PMC · DOI: 10.1186/s12883-024-03846-2 · BMC Neurology · 2024-09-17

## TL;DR

A 23-year-old patient with severe ataxia was diagnosed with SCA1, a rare genetic disorder, due to a large CAG expansion and an intermediate allele in the ATXN1 gene.

## Contribution

This case report highlights a rare SCA1 diagnosis involving an intermediate allele and a large CAG expansion without CAT interruption.

## Key findings

- The patient had a pathogenic 61 CAG repeat and an intermediate 37 CAG repeat in the ATXN1 gene.
- No CAT interruption was found in the CAG repeats, which is crucial for molecular diagnosis and genetic counseling.
- The case shows early-onset and rapid progression of SCA1 despite the presence of an intermediate allele.

## Abstract

Spinocerebellar ataxia type 1, is a rare neurodegenerative disorder with autosomal dominant inheritance belonging to the polyglutamine diseases. The diagnosis of this disease requires genetic testing that may also include the search for CAT interruption of the CAG repeat tract.

One 23-years-old patient suffers from a severe ataxia, with early-onset and rapid progression of the disease. His father might have been affected, but no molecular confirmation has been performed. The genetic results were negative for the Friedreich’s ataxia, spinocerebellar ataxia type 2, 3, 6, 7 and 17. The numbers of CAG repeats in the ATXN1 gene was assessed by fluorescent PCR, tripled-primed PCR and enzymatic digestion for the search of sequence interruption in the CAG repeats. The patient carried one pathogenic allele of 61 CAG and one intermediate allele of 37 CAG in the ATXN1 gene. Both alleles were uninterrupted.

We report a rare case of spinocerebellar ataxia type 1 with an intermediate allele and a large SCA1 expansion. The determination of the absence of CAT interruption brought crucial information concerning this molecular diagnosis, the prediction of the disease and had practical consequences for genetic counseling.

The online version contains supplementary material available at 10.1186/s12883-024-03846-2.

## Linked entities

- **Genes:** ATXN1 (ataxin 1) [NCBI Gene 6310]
- **Diseases:** Spinocerebellar ataxia type 1 (MONDO:0008119), Friedreich’s ataxia (MONDO:0100339), spinocerebellar ataxia type 2 (MONDO:0008458), spinocerebellar ataxia type 3 (MONDO:0007182), spinocerebellar ataxia type 6 (MONDO:0008457), spinocerebellar ataxia type 7 (MONDO:0016163), spinocerebellar ataxia type 17 (MONDO:0011781)

## Full-text entities

- **Genes:** ATXN1 (ataxin 1) [NCBI Gene 6310] {aka ATX1, D6S504E, SCA1}, CAT (catalase) [NCBI Gene 847]
- **Diseases:** PRESENTATION (MESH:D001946), Friedreich's ataxia (MESH:D005621), polyglutamine diseases (MESH:D030342), neurodegenerative disorder (MESH:D019636), Spinocerebellar ataxia type 1 (MESH:D020754), ataxia (MESH:D001259)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11406724/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11406724/full.md

---
Source: https://tomesphere.com/paper/PMC11406724